Detection Rate of (18)F-Labeled PSMA PET/CT in Biochemical Recurrent Prostate Cancer: A Systematic Review and a Meta-Analysis

Background: The use of radiolabeled prostate-specific membrane antigen positron emission tomography/computed tomography (PSMA PET/CT) for biochemical recurrent prostate cancer (BRPCa) is increasing worldwide. Recently, (18)F-labeled PSMA agents have become available. We performed a systematic review...

Descripción completa

Detalles Bibliográficos
Autores principales: Treglia, Giorgio, Annunziata, Salvatore, Pizzuto, Daniele A., Giovanella, Luca, Prior, John O., Ceriani, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562935/
https://www.ncbi.nlm.nih.gov/pubmed/31126071
http://dx.doi.org/10.3390/cancers11050710

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562935/
https://www.ncbi.nlm.nih.gov/pubmed/31126071
http://dx.doi.org/10.3390/cancers11050710

Ejemplares similares